{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:18:27Z","timestamp":1791609507902,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00115-025-01916-5","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:39:40Z","timestamp":1763638780000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimierung der Arbeit von Ged\u00e4chtnisambulanzen nach \u201evalue-based healthcare\u201c\u00a0\u2013 ein Ansatz aus der Klinik f\u00fcr Psychiatrie und Psychotherapie des ZI Mannheim","Optimization of the work of outpatient memory clinics from the perspective of value-based healthcare\u2014An approach from the Clinic for Psychiatry and Psychotherapy of the ZI Mannheim"],"prefix":"10.1007","volume":"97","author":[{"given":"Lucrezia","family":"Hausner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria S.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Kalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sch\u00f6nberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Katrin","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Fehrenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"26","key":"1916_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter\u00a0ME (2010) What is value in health care? N\u00a0Engl J Med 363(26):2477\u20132481. https:\/\/doi.org\/10.1056\/NEJMp1011024","journal-title":"N Engl J Med"},{"issue":"10","key":"1916_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jama.2016.11698","volume":"316","author":"ME Porter","year":"2016","unstructured":"Porter\u00a0ME, Lee\u00a0TH (2016) From volume to value in health care. JAMA 316(10):1047. https:\/\/doi.org\/10.1001\/jama.2016.11698","journal-title":"JAMA"},{"issue":"1","key":"1916_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12913-022-07489-2","volume":"22","author":"DJ van Staalduinen","year":"2022","unstructured":"van Staalduinen\u00a0DJ, van den Bekerom\u00a0P, Groeneveld\u00a0S, Kidanemariam\u00a0M, Stiggelbout\u00a0AM, van den Akker-van Marle\u00a0ME (2022) The implementation of value-based healthcare: a\u00a0scoping review. BMC Health Serv Res 22(1):270. https:\/\/doi.org\/10.1186\/s12913-022-07489-2","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"1916_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMp1511701","volume":"374","author":"ME Porter","year":"2016","unstructured":"Porter\u00a0ME, Larsson\u00a0S, Lee\u00a0TH (2016) Standardizing patient outcomes measurement. N\u00a0Engl J Med 374(6):504\u2013506. https:\/\/doi.org\/10.1056\/NEJMp1511701","journal-title":"N Engl J Med"},{"issue":"8","key":"1916_CR5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/healthcare11081187","volume":"11","author":"F Krebs","year":"2023","unstructured":"Krebs\u00a0F et\u00a0al (2023) Transforming health care delivery towards value-based health care in Germany: a\u00a0Delphi survey among stakeholders. Healthcare 11(8):1187. https:\/\/doi.org\/10.3390\/healthcare11081187","journal-title":"Healthcare"},{"key":"1916_CR6","unstructured":"DGN e. V, DGPPN e. V S3-Leitlinie Demenzen, Version\u00a04. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/038-013. Zugegriffen: 13. Nov. 2024"},{"issue":"4","key":"1916_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3233\/JAD-240728","volume":"101","author":"S Mattke","year":"2024","unstructured":"Mattke\u00a0S et\u00a0al (2024) Current capacity for diagnosing Alzheimer\u2019s disease in Germany and implications for wait times. J\u00a0Alzheimer\u2019s Dis 101(4):1249\u20131259. https:\/\/doi.org\/10.3233\/JAD-240728","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"1916_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims\u00a0JR et\u00a0al (2023) Donanemab in early symptomatic Alzheimer disease. JAMA 330(6):512. https:\/\/doi.org\/10.1001\/jama.2023.13239","journal-title":"JAMA"},{"issue":"1","key":"1916_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck\u00a0CH et\u00a0al (2023) Lecanemab in early Alzheimer\u2019s disease. N\u00a0Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"1916_CR10","unstructured":"European Medicines Agency Leqembi. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi. Zugegriffen: 30. Sept. 2025"},{"key":"1916_CR11","unstructured":"European Medicines Agency Kinsula. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kisunla. Zugegriffen: 30. Sept. 2025"},{"key":"1916_CR12","unstructured":"Deutsche Alzheimer Gesellschaft (2022) Die H\u00e4ufigkeit von Demenzerkrankungen. https:\/\/www.deutsche-alzheimer.de\/fileadmin\/Alz\/pdf\/factsheets\/infoblatt1_haeufigkeit_demenzerkrankungen_dalzg.pdf\nZugegriffen 04.11.2025"},{"key":"1916_CR13","unstructured":"Deutsches \u00c4rzteblatt (2023) Neue Alzheimertherapien sind Herausforderung f\u00fcr das Gesundheitssystem. Dtsch \u00c4rztebl"},{"key":"1916_CR14","unstructured":"Jessen F, Perneczky R, von Arnim C, Schulz JB (2023) Fr\u00fcherkennung von Demenz: Ged\u00e4chtnisambulanzen mit Kernkompetenz f\u00fcr Alzheimer. Dtsch \u00c4rztebl Int: 816"},{"key":"1916_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.ZEFQ.2017.08.002","volume":"130","author":"H Raspe","year":"2018","unstructured":"Raspe\u00a0H (2018) Value based health care (VbHC): woher und wohin? Z\u00a0Evid Fortbild Qual Gesundhwes 130:8\u201312. https:\/\/doi.org\/10.1016\/J.ZEFQ.2017.08.002","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"1916_CR16","doi-asserted-by":"publisher","unstructured":"Sch\u00f6nberger et. al. (im Druck) Prozessoptimierung in Ged\u00e4chtnisambulanzen orientiert an Value-based Healthcare (VBHC). Monitor Versorgungsforschung (06\/25):71-77. https:\/\/doi.org\/10.24945\/MVF.06.25.1866-0533.2780","DOI":"10.24945\/MVF.06.25.1866-0533.2780"},{"issue":"4","key":"1916_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/eurjcn\/zvae012","volume":"23","author":"LN Bulto","year":"2024","unstructured":"Bulto\u00a0LN, Davies\u00a0E, Kelly\u00a0J, Hendriks\u00a0JM (2024) Patient journey mapping: emerging methods for understanding and improving patient experiences of health systems and services. Eur J Cardiovasc Nurs 23(4):429\u2013433. https:\/\/doi.org\/10.1093\/eurjcn\/zvae012","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"1","key":"1916_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/healthcare11010098","volume":"11","author":"E Bandurska","year":"2022","unstructured":"Bandurska\u00a0E (2022) The voice of patients really matters: using patient-reported outcomes and experiences measures to assess effectiveness of home-based integrated care\u2014A scoping review of practice. Healthcare 11(1):98. https:\/\/doi.org\/10.3390\/healthcare11010098","journal-title":"Healthcare"},{"issue":"Supplement_1","key":"1916_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/milmed\/usad014","volume":"189","author":"R Newnam","year":"2023","unstructured":"Newnam\u00a0R, Migliore\u00a0L, Ransom\u00a0JC (2023) Standardizing evidence-based practice review processes across the defense health agency enterprise. Mil Med 189(Supplement_1):39\u201344. https:\/\/doi.org\/10.1093\/milmed\/usad014","journal-title":"Mil Med"},{"key":"1916_CR20","volume-title":"State-Trait-Anxiety Inventory nach Spielberger","author":"J Grimm","year":"2009","unstructured":"Grimm\u00a0J (2009) State-Trait-Anxiety Inventory nach Spielberger (Deutsche Lang- und Kurzversion)"},{"key":"1916_CR21","volume-title":"Manual for the state-trait anxiety inventory (self-evaluation questionnaire)","author":"CD Spielberger","year":"1970","unstructured":"Spielberger\u00a0CD (1970) Manual for the state-trait anxiety inventory (self-evaluation questionnaire). Palo Alto"},{"issue":"4","key":"1916_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/1742395309348072","volume":"5","author":"PC Gugiu","year":"2009","unstructured":"Gugiu\u00a0PC, Coryn\u00a0C, Clark\u00a0R, Kuehn\u00a0A (2009) Development and evaluation of the short version of the patient assessment of chronic illness care instrument. Chronic Illn 5(4):268\u2013276. https:\/\/doi.org\/10.1177\/1742395309348072","journal-title":"Chronic Illn"},{"issue":"10","key":"1916_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman\u00a0M et\u00a0al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20(10):1727\u20131736. https:\/\/doi.org\/10.1007\/s11136-011-9903-x","journal-title":"Qual Life Res"},{"key":"1916_CR24","unstructured":"Schmidtke A, Fleckenstein P, Moises W, Beckmann H (1988) Untersuchungen zur Reliabilit\u00e4t und Validit\u00e4t einer deutschen Version der Montgomery-Asberg Depression-Rating Scale (MADRS) [Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS). Schweizer Arch Neurol Psychiatr 139(2)"},{"issue":"3","key":"1916_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein\u00a0MF, Folstein\u00a0SE, McHugh\u00a0PR (1975) Mini-mental state\u2018. J\u00a0Psychiatr Res 12(3):189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"issue":"3","key":"1916_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1001\/jamainternmed.2023.7669","volume":"184","author":"T Ramesh","year":"2024","unstructured":"Ramesh\u00a0T, Kadakia\u00a0K, Moura\u00a0L (2024) Transforming value-based dementia care\u2014implications for the GUIDE model. JAMA Intern Med 184(3):237. https:\/\/doi.org\/10.1001\/jamainternmed.2023.7669","journal-title":"JAMA Intern Med"},{"key":"1916_CR27","unstructured":"E. C. D.-G. for H. and F.\u00a0Safety, Defining value in \u2018value-based healthcare\u2019\u2014Report of the Expert Panel on Effective Ways of Investing in Health (EXPH). Publications Office, 2019. doi: doi\/10.2875\/35471."},{"issue":"9","key":"1916_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00108-024-01767-3","volume":"65","author":"V Steinbeck","year":"2024","unstructured":"Steinbeck\u00a0V, Fresemann\u00a0ML, Busse\u00a0R (2024) Value-based healthcare\u2018 als M\u00f6glichkeit zur PatientInnensteuerung auf individueller und Systemebene. Die Inn Medizin 65(9):890\u2013898. https:\/\/doi.org\/10.1007\/s00108-024-01767-3","journal-title":"Die Inn Medizin"},{"key":"1916_CR29","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte \u00c4nderungsvorschlag f\u00fcr den OPS 2024. https:\/\/multimedia.gsb.bund.de\/BfArM\/downloads\/klassifikationen\/ops\/vorschlaege\/vorschlaege2026\/ops2026-127-komplexdiagnostik-demenz.pdf"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01916-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01916-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01916-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:10:28Z","timestamp":1772460628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01916-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01916-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Fr\u00f6lich hat zwischen 2020 und 2025 Honorare f\u00fcr Beratung und Vortr\u00e4ge erhalten von: Biogen, BioVie, Eli Lilly, Eisai, GE Healthcare, Grifols, Janssen, Neurimmune, Noselab, NovoNordisk, Roche, TauRX, Schwabe, Medscape, Medfora und FOMF sowie institutionelle F\u00f6rderung von Hoffmann-La Roche. Zudem steht LF in Verbindung zur German Society of Psychiatry, Psychotherapy and Nervous Diseases (Guideline committee), European Alzheimer Disease Consortium, German Network of Memory Clinics, Alzheimer Europe, Alzheimer Society Baden-W\u00fcrttemberg. L.\u00a0Hausner erhielt Honorare f\u00fcr Vortr\u00e4ge von MedTriX (2021, 2022 und 2023), Medfora (2021) und Roche (2021) und Roche-Beratert\u00e4tigkeit (2022). G.S.\u00a0Benson hat in 2022 Honorare f\u00fcr Beratung und Vortr\u00e4ge erhalten von Roche Pharma. F.\u00a0Jessen hat zwischen 2022 und 2025 Honorare f\u00fcr Beratung und Vortr\u00e4ge erhalten von: Abbvie, AC immune, Biogen, Eli Lilly, Eisai, GE Healthcare, Grifols, Janssen-Cliag und Roche Pharma sowie institutionelle Forschungsf\u00f6rderung von Roche Pharma. A.-K.\u00a0Schild hat zwischen 2022 und 2025 Honorare f\u00fcr Vortr\u00e4ge erhalten von: Novo Nordisk Pharma GmbH und Lilly Deutschland GmbH. S.\u00a0Fehrenbach steht in einem Besch\u00e4ftigungsverh\u00e4ltnis zu der Roche Pharme AG und besitzt Aktien der F.\u00a0Hoffmann-La Roche AG. B.\u00a0Hennig steht in einem Besch\u00e4ftigungsverh\u00e4ltnis mit der Roche Diagnostics Deutschland GmbH und besitzt Aktien der F.\u00a0Hoffmann-La Roche AG. A.\u00a0Knudsen stand von 2023 bis 2024 in einem Besch\u00e4ftigungsverh\u00e4ltnis bei der Roche Pharma AG und besa\u00df in diesem Zeitraum Aktien der F.\u00a0Hoffmann-La Roche AG. Er war von 2024 bis 2025 bei der Novartis Pharma GmbH und ist seit 2025 bei der Roche Diagnostics Deutschland GmbH angestellt. A.\u00a0Steinmetz, M.\u00a0Kalla und A.\u00a0Sch\u00f6nberger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Das Projekt wurde mit Zustimmung der zust\u00e4ndigen Ethikkommission der Medizinischen Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg (Antragsnummer: 2023-601) sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen Teilnehmenden liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}